Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. The malignant CRC that undergoes metastasis in the advanced stage is usually refractory to existing chemotherapy and shows a poor prognosis. However, to date, efficient targeted-therapy for metastatic CRC is ill-defined...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Seyung S., Oliva, Bryant, Dwabe, Sami, Vadgama, Jaydutt V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922839/
https://www.ncbi.nlm.nih.gov/pubmed/27279256
http://dx.doi.org/10.3892/ijo.2016.3546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922839/
https://www.ncbi.nlm.nih.gov/pubmed/27279256
http://dx.doi.org/10.3892/ijo.2016.3546

Ejemplares similares